121 related articles for article (PubMed ID: 11592861)
1. Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms.
Delgado G; Puentes F; Moreno A; Patarroyo ME
Pharmacol Res; 2001 Oct; 44(4):281-6. PubMed ID: 11592861
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Sensitivity of Cutaneous
Ginouvès M; Simon S; Nacher M; Demar M; Carme B; Couppié P; Prévot G
Am J Trop Med Hyg; 2017 May; 96(5):1143-1150. PubMed ID: 28167598
[TBL] [Abstract][Full Text] [Related]
3. Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug.
Varela M RE; Muñoz DL; Robledo SM; Kolli BK; Dutta S; Chang KP; Muskus C
Exp Parasitol; 2009 Jun; 122(2):134-9. PubMed ID: 19303871
[TBL] [Abstract][Full Text] [Related]
4. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
Ephros M; Bitnun A; Shaked P; Waldman E; Zilberstein D
Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518
[TBL] [Abstract][Full Text] [Related]
5. Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.
Barrera MC; Rojas LJ; Weiss A; Fernandez O; McMahon-Pratt D; Saravia NG; Gomez MA
Acta Trop; 2017 Dec; 176():355-363. PubMed ID: 28843396
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes.
Lucumi A; Robledo S; Gama V; Saravia NG
Antimicrob Agents Chemother; 1998 Aug; 42(8):1990-5. PubMed ID: 9687395
[TBL] [Abstract][Full Text] [Related]
7. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
8. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.
Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM
Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203
[TBL] [Abstract][Full Text] [Related]
9. Glucantime resistant Leishmania promastigotes are sensitive to pentostam.
Moreira ES; Guerra JB; Petrillo-Peixoto Mde L
Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539
[TBL] [Abstract][Full Text] [Related]
10. Natural resistance to meglumine antimoniate is associated with treatment failure in cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis.
Fernández OL; Rosales-Chilama M; Sánchez-Hidalgo A; Gómez P; Rebellón-Sánchez DE; Regli IB; Díaz-Varela M; Tacchini-Cottier F; Saravia NG
PLoS Negl Trop Dis; 2024 May; 18(5):e0012156. PubMed ID: 38709850
[TBL] [Abstract][Full Text] [Related]
11. Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine.
Cortázar TM; Coombs GH; Walker J
Exp Parasitol; 2007 Aug; 116(4):475-82. PubMed ID: 17466980
[TBL] [Abstract][Full Text] [Related]
12. [Differential expression of proteins in Leishmania (Viannia) panamensis associated with mechanisms of resistance to meglumine antimoniate].
Peláez RG; Muskus CE; Cuervo P; Marín-Villa M
Biomedica; 2012 Sep; 32(3):418-29. PubMed ID: 23715190
[TBL] [Abstract][Full Text] [Related]
13. An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
Gebre-Hiwot A; Tadesse G; Croft SL; Frommel D
Acta Trop; 1992 Aug; 51(3-4):237-45. PubMed ID: 1359751
[TBL] [Abstract][Full Text] [Related]
14. Resistance of
Regli IB; Fernández OL; Martínez-Salazar B; Gómez MA; Saravia NG; Tacchini-Cottier F
Front Immunol; 2018; 9():3040. PubMed ID: 30622537
[No Abstract] [Full Text] [Related]
15. Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum.
Sereno D; Holzmuller P; Lemesre JL
Acta Trop; 2000 Jan; 74(1):25-31. PubMed ID: 10643904
[TBL] [Abstract][Full Text] [Related]
16. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR
Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570
[TBL] [Abstract][Full Text] [Related]
17. Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.
Carrió J; de Colmenares M; Riera C; Gállego M; Arboix M; Portús M
Exp Parasitol; 2000 Jul; 95(3):209-14. PubMed ID: 10964649
[TBL] [Abstract][Full Text] [Related]
18. Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages.
Berman JD; Lee LS
J Parasitol; 1984 Apr; 70(2):220-5. PubMed ID: 6088749
[TBL] [Abstract][Full Text] [Related]
19. Effect of glucantime on field and patient isolates of New World Leishmania: use of growth parameters of promastigotes to assess antimony susceptibility.
Moreira ES; Anacleto C; Petrillo-Peixoto ML
Parasitol Res; 1998 Sep; 84(9):720-6. PubMed ID: 9766900
[TBL] [Abstract][Full Text] [Related]
20. Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines.
Ferreira-Pinto KC; Miranda-Vilela AL; Anacleto C; Fernandes AP; Abdo MC; Petrillo-Peixoto ML; Moreira ES
Can J Microbiol; 1996 Sep; 42(9):944-9. PubMed ID: 8864217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
